AIL
NVAX icon

AGF Investments LLC’s Novavax NVAX Stock Holding History

AGF Investments LLC’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,600
Closed -$471K – 487
2021
Q1 		$471K Sell
2,600
-5,772
-69% -$1.15M 0.06% 234
2020
Q4 		$934K Buy
+8,372
New +$890K 0.11% 65

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AGF Investments LLC's NVAX Position: Q2 2021 in Review

AGF Investments LLC sold out of Novavax (NVAX) in Q2 2021, closing a stake of 2,600 shares — an estimated $471K sold.

AGF Investments LLC first reported a position in NVAX in Q4 2020 and held it in 2 quarters. The position peaked at $934K in Q4 2020. 407 funds tracked by Wall St. Rank hold NVAX as of Q2 2021.

  • AGF Investments LLC reported no remaining Novavax position as of Q2 2021 after selling out during the quarter.
  • AGF Investments LLC sold 2,600 Novavax shares in Q2 2021, an estimated $471K.
  • AGF Investments LLC first reported a position in Novavax in Q4 2020 and held it in 2 quarters.
  • AGF Investments LLC's Novavax position peaked at $934K in Q4 2020.
  • 407 funds tracked by Wall St. Rank held Novavax as of Q2 2021.

Based on AGF Investments LLC's 13F filing for Q2 2021, filed 12 Aug 2021.